Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

733 ARTÍCULOS , VIENDO DEL 601 AL 615

Alzheimer's disease: a clinical update on diagnosis and treatment

Shir D, Lachner C.

Neurol Neurochir Pol. 2026;60(2):128-137. doi: 10.5603/pjnns.109190. Epub 2026 Feb 17.

A paradigm of the diagnosis and treatment for the whole process of Alzheimer's disease

Shi J, Du Y, Wang H, Zhang N, Chen W, Ni J, Lu X, Sun Y, Wang G, Liu J, Zhang W, Wei M, Li T, Zhou B, Li F, Wei C, Yao L, Xie H, Tian J; ADC Guidelines Working Group of the Chinese Aging Well Association.

Ann Med. 2026 Dec;58(1):2672193. doi: 10.1080/07853890.2026.2672193. Epub 2026 May 20.

Extracellular Vesicles in Alzheimer's Disease: Mechanisms, Biomarkers, and Therapeutic Engineering

Wang L, Mao L, Zong X.

Int J Mol Sci. 2026 Apr 29;27(9):3974. doi: 10.3390/ijms27093974.

Tau in Alzheimer's disease: Shaping the future patient journey

Mummery CJ, Li-Hsian CC, Lasagna-Reeves CA, Ossenkoppele R, Rowe CC, Scharre DW, Wang H, Kyaga S, Cummings JL.

J Prev Alzheimers Dis. 2026 Feb;13(2):100447. doi: 10.1016/j.tjpad.2025.100447. Epub 2026 Jan 1.

Disease modifying treatments for Alzheimer's disease: Clinician perspectives

Pennington C, Apurva P, Chen A, Duncan A, Mackay G, Masters H, Paramore K, Russ T, Skinner H, Zeidler M.

J Alzheimers Dis. 2026 May;111(1):125-131. doi: 10.1177/13872877261429859. Epub 2026 Mar 25.

The role of astrocytes in Alzheimer's disease: Pathophysiology, biomarkers, and therapeutic potential

Abedin MJ, Kastanenka KV.

J Alzheimers Dis. 2026 Mar;110(1):26-45. doi: 10.1177/13872877251411561. Epub 2026 Jan 13.

Nanomaterials for Alzheimer's disease: emerging strategies in diagnosis and therapy

Na Y, Bai J, Zhang N, Geng F, Wang X.

J Nanobiotechnology. 2026 Mar 21;24(1):398. doi: 10.1186/s12951-026-04281-w.

CSF proteomics of semorinemab Alzheimer's disease trials identifies cell-type specific signatures

Abdel-Haleem AM, Casavant E, Toth B, Teng E, Monteiro C, Pandya NJ, Glock C, Hoogenraad CC, Friedman BA, Yeh FL, Anania VG, Novikova G.

Brain. 2026 Jan 8;149(1):150-162. doi: 10.1093/brain/awaf200.

Serious doubts about amyloid-β (Aβ) biomarkers and anti-Aβ immunotherapy

Høilund-Carlsen PF, Alavi A, Costa T, Neve RL, Revheim ME, Barrio JR.

J Alzheimers Dis. 2026 Apr;110(3):1079-1084. doi: 10.1177/13872877261417548. Epub 2026 Mar 20.

Alzheimer's disease: Time to reassess research and clinical priorities

Wiatrak B, Szeląg A.

Adv Clin Exp Med. 2026 Mar;35(3):397-401. doi: 10.17219/acem/217199.

Alzheimer's disease

Serrano-Pozo A, Escott-Price V, Grinberg LT, Pascoal T, Suárez-Calvet M, Dubois B, Sperling RA.

Lancet. 2026 May 30;407(10544):2241-2262. doi: 10.1016/S0140-6736(26)00198-4.

Clinical Practice Recommendations of the Swiss Society for Neuroradiology: Neuroimaging Standards for Enrollment and Disease Monitoring in Anti-Amyloid Immunotherapies

Wiest R, Radojewski P, Lieb JM, Psychogios M, Benzinger TLS, Franceschi AM, Wanke I, Draganski B, Kurz FT, Lövblad KO.

Neurodegener Dis. 2026;26(2):77-88. doi: 10.1159/000549521. Epub 2025 Nov 12.

The Basis of Anti-Aβ Antibody Therapy: The Toxicity of Aβ Aggregates and the Mechanism of Action of Anti-Aβ Antibodies

Ono K, Noguchi-Shinohara M, Watanabe-Nakayama T.

Intern Med. 2026 Jan 1;65(1):41-45. doi: 10.2169/internalmedicine.4569-24. Epub 2024 Oct 4.

Anti-amyloid β Antibody Therapies for Alzheimer's Disease: Association between the Target of Amyloid β Aggregates and the Clinical Efficacy of Anti-amyloid β Antibody

Noguchi-Shinohara M, Ono K.

Intern Med. 2026 Jan 1;65(1):67-70. doi: 10.2169/internalmedicine.4604-24. Epub 2024 Oct 11.

Experimental Models and Translational Strategies in Neuroprotective Drug Development with Emphasis on Alzheimer's Disease

Niziński P, Szalast K, Makuch-Kocka A, Paruch-Nosek K, Ciechanowska M, Plech T.

Molecules. 2026 Jan 16;31(2):320. doi: 10.3390/molecules31020320.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias